Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: a month ago

Possible Interaction: Dexamethasone and Ovalbumin

supplement:

Ovalbumin

Research Papers that Mention the Interaction

Treated S groups with dexamethasone and both concentrations of ALA lead to significant decrease in TR to methacholine and OA , BALF levels of TP, PLA2, IgE and IL-4 compared to group S (P<0.001 for all case).
Iranian journal of basic medical sciences  •  2019  |  View Paper
Dex inhibited both class I- and class II-restricted presentation of OVA to T cells; this inhibitory effect on antigen presentation was much more potent in immature macrophages than in mature macrophages.
Immune network  •  2014  |  View Paper
… OVA ) sensitization and challenge to evaluate the influence of O3 on the inhibitory effect of dexamethasone on AHR and airway inflammation, and by administration … and the expression of MKP-1.ResultsOzone exposure not only aggravated the pulmonary inflammation and AHR, but also decreased the inhibitory effects of dexamethasone , accompanied ….
Respiratory Research  •  2014  |  View Paper
The TR to both methacholine and OVA in treated animals with dexamethasone and all concentrations of safranal were significantly decreased compared to S group (p < 0.01 to p < 0.001).
Pharmacological reports : PR  •  2014  |  View Paper
RESULTS Maximal changes of respiratory system resistance and elastance induced by OVA challenge were attenuated by dexamethasone (P<0.001), but not by montelukast treatment.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology  •  2004  |  View Paper
Dexamethasone (20 mg/kg, i.p.) and rolipram (1 mg/kg, i.p.) administered 24 and 0.5 h before and 6 h after OA challenge inhibited leucocyte influx, AHR and the early deficiency and later excess of NO.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology  •  2004  |  View Paper
The glucocorticosteroid dexamethasone reduced all the parameters evaluated after Ova or after rmIL-13.
American journal of respiratory cell and molecular biology  •  2002  |  View Paper
Prophylactic treatment with dexamethasone (1mg x kg (-1)) reduced the OVA induced AHR, eosinophilia and mucus cell hyperplasia/metaplasia measured 24h post challenge.
Therapeutic treatment, with dexamethasone (2 mg x kg(-1)), significantly inhibited established airway eosinophilia, measured at 72 h post OVA challenge, only when treatment was initiated at 24h but not 48 h after challenge.
Pulmonary pharmacology & therapeutics  •  2002  |  View Paper
Subcutaneous (s.c.) administration of Dex (50 or 100 micrograms per mouse, -1 h) inhibited eosinophil accumulation into Ova challenged air-pouches by about 70% (P < 0.05) and 75% (P < 0.05), respectively, when compared to controls.
British journal of pharmacology  •  1997  |  View Paper
In immunized animals, gavage or voluntary ingestion of ovalbumin triggers an increase of vascular permeability in the intestine; pretreatment with a mixture of histamine and serotonin antagonists blocked this reaction, but not the aversion; dexamethasone inhibited both the aversion and the increase in permeability.
Scandinavian journal of immunology  •  1997  |  View Paper
Show More